Education
About Us
Working with TipRanks
Follow Us
Intelligent Bio Solutions (INBS)
NASDAQ:INBS
RESEARCH TOOLSreports
INBS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.00 - $3.00
Previous CloseN/A
Volume32.28K
Average Volume (3M)125.25K
Market Cap
$11.82M
Enterprise Value$1.85B
Total Cash (Recent Filing)$2.81M
Total Debt (Recent Filing)$511.18K
Price to Earnings (P/E)―
Beta2.13
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding6,910,279
10 Day Avg. Volume134,386
30 Day Avg. Volume125,255
Financial Highlights & Ratios
PEG Ratio-5.74
Price to Book (P/B)-400.49
Price to Sales (P/S)0.00
P/FCF Ratio-331.40
Enterprise Value/Market Cap156.83
Enterprise Value/Revenue151.07
Enterprise Value/Gross Profit1.07K
Enterprise Value/Ebitda-51.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Intelligent Bio Solutions News
Options Prices
Currently, No data available
---
Ownership Overview
1.36% Insiders
0.61% Mutual Funds
11.04% Other Institutional Investors
86.76% Public Companies and Individual Investors
INBS FAQ
What was Intelligent Bio Solutions’s price range in the past 12 months?
Intelligent Bio Solutions lowest stock price was $1.00 and its highest was $3.00 in the past 12 months.
What is Intelligent Bio Solutions’s market cap?
Intelligent Bio Solutions’s market cap is $11.82M.
When is Intelligent Bio Solutions’s upcoming earnings report date?
Intelligent Bio Solutions’s upcoming earnings report date is Nov 06, 2025 which is in 130 days.
How were Intelligent Bio Solutions’s earnings last quarter?
Intelligent Bio Solutions released its earnings results on May 13, 2025. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.44.
Is Intelligent Bio Solutions overvalued?
According to Wall Street analysts Intelligent Bio Solutions’s price is currently Overvalued.
Does Intelligent Bio Solutions pay dividends?
Intelligent Bio Solutions does not currently pay dividends.
What is Intelligent Bio Solutions’s EPS estimate?
Intelligent Bio Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intelligent Bio Solutions have?
Intelligent Bio Solutions has 6,910,279 shares outstanding.
What happened to Intelligent Bio Solutions’s price movement after its last earnings report?
Intelligent Bio Solutions reported an EPS of -$0.44 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 11.475%.
Which hedge fund is a major shareholder of Intelligent Bio Solutions?
Currently, no hedge funds are holding shares in INBS
Company Description
Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Technical Analysis
Star Equity Holdings
―
Check-Cap
―
Precipio
―
Mainz Biomed B.V.
―
bioAffinity Technologies, Inc.
―